FDA Recalls Tri-Mix ST2 Injectable Due to Sterility Concerns
The Compounding Pharmacy of America is recalling Tri-Mix ST2 Injectable nationwide due to FDA inspection findings of GMP violations that may impact sterility.
- Product
- Tri-Mix ST2 (30 mg/3 mg/100 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN
- Category
- Drug
- Distribution
- Distributed nationwide